Ancient herbs meet modern viruses in fight against superbug pneumonia
NCT ID NCT07612605
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial will test a combination of a Chinese herbal formula (Yiqi Huoxue Jiedu) and bacteriophages (viruses that target bacteria) in 250 people with severe pneumonia caused by drug-resistant bacteria. The goal is to see if this combo can clear the infection faster and reduce deaths. The study is not yet recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Yiqi Huoxue Jiedu formula (herbal mix) and bacteriophages (viruses that kill bacteria)
What this could lead to
If it works, this could point toward a new way to treat severe pneumonia caused by drug-resistant bacteria, potentially lowering death rates.
What could go wrong
This is a very early (Phase 1) trial, so safety and effectiveness are not yet proven. The combination therapy may not work better than standard care, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
1st Medical Center of Chinese PLA General Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
8th Medical Center of Chinese PLA General Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Guangzhou Medical University
Guangdong, Guangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangdong, Guangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••